Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy

Abstract Patients with chronic hepatitis B (CHB) undergoing interferon (IFN)-α-based therapies often exhibit a poor HBeAg serological response. Thus, there is an unmet need for new therapies aimed at CHB. This study comprised two clinical trials, including 130 CHB patients, who were treatment-naïve;...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dongyao Wang, Binqing Fu, Xiaokun Shen, Chuang Guo, Yanyan Liu, Junfei Zhang, Rui Sun, Ying Ye, Jiabin Li, Zhigang Tian, Haiming Wei
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
R
Acceso en línea:https://doaj.org/article/21b417eb6d294715b19d0a664f3c43a8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares